Introduction
As a consequence of the extensive use of cesarean sections, the
incidence of placenta accreta spectrum (PAS) disorders, characterized by
abnormal invasion of trophoblastic tissue through the myometrium and
uterine serosa, has been growing considerably1. This
condition exposes mothers to the risk of massive bleeding (average blood
loss ~2-5 L2) and death. The maternal
mortality rate in its most severe form (placenta percreta) is reportedly
7%3.
The most recent guidelines4 suggest producing
in-hospital protocols that are shared among all involved professionals
and establishing a step-by-step plan, from ultrasound-based detection of
placenta previa to post-surgery management.